This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 Feb;21(1):5-7.

doi: 10.1007/s10557-007-6000-z.

Metabolic modulation in heart failure: the coming of age

Houman Ashrafian, Michael P Frenneaux

PMID: 17285357
DOI: 10.1007/s10557-007-6000-z

Editorial

Metabolic modulation in heart failure: the coming of age

Houman Ashrafian et al. Cardiovasc Drugs Ther. 2007 Feb.

. 2007 Feb;21(1):5-7.

doi: 10.1007/s10557-007-6000-z.

Authors

Houman Ashrafian, Michael P Frenneaux

PMID: 17285357
DOI: 10.1007/s10557-007-6000-z

No abstract available

PubMed Disclaimer

Comment on

CVT-4325 inhibits myocardial fatty acid uptake and improves left ventricular systolic function without increasing myocardial oxygen consumption in dogs with chronic heart failure.
Imai M, Rastogi S, Sharma N, Chandler MP, Sharov VG, Blackburn B, Belardinelli L, Stanley WC, Sabbah HN. Imai M, et al. Cardiovasc Drugs Ther. 2007 Feb;21(1):9-15. doi: 10.1007/s10557-006-0496-5. Cardiovasc Drugs Ther. 2007. PMID: 17119875

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer
Medical
- MedlinePlus Health Information